Dr Imelda Juniarsih

Investment Associate Director

6 past transactions

ImmuONE

Seed Round in 2025
ImmuONE specializes in inhalation toxicology, offering solutions for irritation sensitization, alveolar clearance, and inflammation. They provide human alveolar macrophage responses, epithelial cell culture platforms, and testing services, using advanced respiratory tissue models to deliver reliable results.

Neobe Therapeutics

Seed Round in 2024
Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.

ImmuONE

Venture Round in 2023
ImmuONE specializes in inhalation toxicology, offering solutions for irritation sensitization, alveolar clearance, and inflammation. They provide human alveolar macrophage responses, epithelial cell culture platforms, and testing services, using advanced respiratory tissue models to deliver reliable results.

Bastion Therapeutics

Venture Round in 2023
Bastion Therapeutics is a preclinical stage biotechnology company focused on developing innovative anti-inflammatory cell therapies. Utilizing its proprietary platform technology, the company aims to enhance regulatory T cells (Tregs) within the immune system. By targeting neuroinflammation in critical areas of the central nervous system, Bastion Therapeutics seeks to protect neurons and improve synaptic connectivity, ultimately helping patients to maintain cognitive function and prevent deterioration. Through its research and development efforts, the company is positioning itself to address significant unmet medical needs in the realm of neuroinflammatory conditions.

NunaBio

Seed Round in 2023
NunaBio is a privately-owned specialist DNA development company based in England, United Kingdom. The company focuses on chemical and biological technologies, providing a diverse array of products and services, including long and short deoxyribonucleic acid products available in various scales, from microgram to gram. NunaBio is involved in contract research and development, as well as manufacturing, offering capabilities in cell therapies, vaccines, diagnostics, gene therapies, and advanced DNA biosensing. By delivering these innovative solutions, NunaBio aims to support healthcare professionals in their efforts to treat patients effectively.

Transdermal Diagnostics

Seed Round in 2022
Transdermal Diagnostics is a technology platform focused on the prevention, diagnosis, and management of chronic conditions, starting with diabetes. It offers a wearable system that provides needle-free, continuous glucose monitoring through affordable disposable patches, enabling people with diabetes and prediabetes to gain biological insights and make informed decisions for healthier living.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.